Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 2,872,000 | 2,955,800 | 2,894,200 | 2,726,800 | 2,839,300 |
| Cost of Goods | 378,500 | 416,900 | 370,300 | 313,000 | 331,900 |
| Gross Profit | 2,493,499 | 2,538,900 | 2,523,900 | 2,413,800 | 2,507,399 |
| Operating Expenses | 1,606,500 | 1,114,500 | 1,063,700 | 1,035,400 | 1,340,300 |
| Operating Income | 887,500 | 1,425,300 | 1,460,500 | 1,378,400 | 1,168,200 |
| Other Income | -49,300 | -58,100 | -58,500 | -52,800 | -82,400 |
| Pre-tax Income | 838,200 | 1,367,200 | 1,402,000 | 1,325,600 | 1,085,800 |
| Income Tax | 190,300 | 337,000 | 353,600 | 356,400 | 257,100 |
| Net Income Continuous | 647,900 | 1,030,200 | 1,048,400 | 969,200 | 828,700 |
| Minority Interests | -1,300 | -2,700 | -1,400 | -1,700 | -2,800 |
| Net Income | $649,200 | $1,032,900 | $1,049,800 | $970,900 | $831,500 |
| EPS Basic Total Ops | 3.01 | 4.72 | 4.79 | 4.44 | 3.78 |
| EPS Basic Continuous Ops | 3.00 | 4.71 | 4.79 | 4.43 | 3.76 |
| EPS Diluted Total Ops | 3.00 | 4.71 | 4.79 | 4.43 | 3.77 |
| EPS Diluted Continuous Ops | 3.00 | 4.70 | 4.78 | 4.42 | 3.75 |
| EBITDA(a) | $1,064,900 | $1,605,500 | $1,635,900 | $1,528,100 | $1,324,300 |